Status:
COMPLETED
Potassium Flux in Hemodialysis Patients
Lead Sponsor:
Washington University School of Medicine
Conditions:
Hemodialysis
Eligibility:
All Genders
18+ years
Brief Summary
Current practice of outpatient hemodialysis entails prescription of standard electrolyte concentrations based upon patient prescription history and monthly serum electrolyte measurements. Dialysate co...
Detailed Description
This is a prospective, cross-sectional study utilizing a study population at Chromalloy American Kidney Center, an outpatient dialysis unit, which currently serves approximately 150 End Stage Renal Di...
Eligibility Criteria
Inclusion
- Age \>18 years
- Consistent thrice weekly in center hemodialysis as defined as no missed sessions in the last 30 days.
- Goal Kt/V Urea (\>1.2, which suggests adequate dialysis based on KDOQI guidelines) for at least 3 months
- Serum potassium 3.5-8.0 mEq/L
- Hemoglobin of \>8.0g/dL
Exclusion
- Age \<18 years
- Evidence of residual renal function as defined by \>100mL of urine output per day
- Those whom do not have capacity to consent
- Change in dialysis prescription within the past 30 days
- 12-lead ECG shows non-sinus cardiac rhythm (atrial fibrillation, atrial flutter, or paced rhythm)
Key Trial Info
Start Date :
May 21 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04287010
Start Date
May 21 2019
End Date
November 30 2020
Last Update
January 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington Univeristy in St Louis
St Louis, Missouri, United States, 63110